Aptevo Therapeutics Inc. ("Aptevo") (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, today announced that it will present two new posters at the Society for Immunotherapy of Cancer's (SITC) 35th Virtual Annual Meeting, to be held from Monday, November 9, 2020 to Saturday, November 14, 2020.
The posters will provide updates on APVO603, which is wholly owned by Aptevo Therapeutics, and the phase 1-ready ALG.APV-527 developed in partnership with Alligator Bioscience.
The abstracts and the accompanying posters will be available in the Virtual Poster Hall to registered attendees from 8:00 am EST on Monday, November 9, until the Virtual Poster Hall closes on December 31, 2020 on the SITC abstract website. Details will also be posted on the Aptevo Therapeutics website.
https://finance.yahoo.com/news/aptevo-therapeutics-present-society-immunotherapy-140000684.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.